Online Pharmacy US

Men with signs of be nign prostatic hyperplasia can be helped with a daily dose of erectile dysfunction drug tadalafil (marketed as Cialis) to relieve associated lower urinary tract symptoms, according to a new study. Researchers from the University of Texas Southwestern Medical Center at Dallas, Northwestern University and Lilly Research Laboratories report on a randomized, double-blind, placebo-controlled study of over 1,000 men in 10 countries. (more…)

This study was done to evaluate whether the Einstein nanoparticles, which have been shown to penetrate the skin, might allow the targeted delivery of compounds that treat ED and thereby avoid the drugs’ systemic effect s.

An effective topical therapy could be especially significant for those ED patients – particularly men with diabetes – who have reduced levels of nitric oxide (NO), the signaling molecule that dilates blood vessels (more…)

Early data from an NIMH-sponsored double-blind study of 24 war veterans shows a marked reduction in acoustic startle ─ the reflex response to sudden loud sounds ─ in those treated with v irtual reality exposure therapy combined with either d-cycloserine, an antibiotic that has been shown to facilitate the extinction of fear memories; pill placebo; or the anti-anxiety medication alprazolam (Xanax). (Source: National Institute of Mental (more…)

NEW YORK, August 19, 2008 – Men with signs of benign prostatic hyperplasia (BPH) can be helped with a daily dose of erectile dysfunction drug tadalafil (Cialis) to relieve associated lower urinary tract symptoms (LUTS), according to a new… (Source: Drugs.com – Pharma News)

MedWorm Message: Get the very latest Swine Flu news via the MedWorm Swine Flu RSS news feed – updated hourly from thousands of a uthoritative health and news (more…)

The first human trial of gene transfer therapy for erectile dysfunction (ED) indicates that gene therapy that lasts for month s and eliminates the patient’s need for on-demand drugs (such as Viagra and Cialis), could become the future treatment of choice for this common problem, according to a paper in the most recent issue of Human Gene Therapy. (Source: EurekAlert! – Biology)

Early data from an NIMH-sponsored double-blind study of 24 war veterans shows a marked reduction in acoustic startle ─ the refle x response to sudden loud sounds ─ in those treated with virtual reality exposure therapy combined with either d-cycloserine, an antibiotic that has been shown to facilitate the extinction of fear memories; pill placebo; or the anti-anxiety medication alprazolam (Xanax). (Source: National Institute of Mental (more…)

The first human trial of gene transfer therapy for erectile dysfunction (ED) indicates that gene therapy that lasts for months and eliminates the patient’s need for on-demand drugs (such as Viagra and Cialis), could become the future treatment of choice for this common problem, according to a paper in the most recent issue of Human Gene Therapy. [click link for full article] (Source: Health News from Medic al News Today)

Men with signs of benign prostatic hyperplasia can be helped with a daily dose of erectile dysfunction drug tadalafil (marketed as Cialis) to relieve associated lower urinary tract symptoms, according to a new study. Researchers from the University of Texas Southwestern Medical Center at Dallas, Northwestern University and Lilly Research Laboratories report on a randomized, double-blind, placebo-controlled study of over 1,000 men in 10 countries. (more…)

The first human trial of gene transfer therapy for erectile dysfunction (ED) indicates that gene therapy that lasts for months and eliminates the patient’s need for on-demand drugs (such as Viagra and Cialis), could become the future t reatment of choice for this common problem, according to a paper in the most recent issue of Human Gene Therapy. [click link for full article] (Source: Genetics News From Medical News Today)

MedWorm Message: (more…)

This study was done to eva luate whether the Einstein nanoparticles, which have been shown to penetrate the skin, might allow the targeted delivery of compounds that treat ED and thereby avoid the drugs’ systemic effects.

An effective topical therapy could be especially significant for those ED patients – particularly men with diabetes – who have reduced levels of nitric oxide (NO), the signaling molecule that dilat es blood vessels responsible (more…)